Overview

Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
0
Participant gender:
All
Summary
This study compares the use of intravitreous triamcinolone and laser therapy to treat maculopahty in patients with type 2 diabetes mellitus in a short-tem period of 6 months
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:

- patients with type 2 DM, diffuse macular oedema secondary to diabetic retinopathy,
seen at the Centre of Reference for Diabetic Retinopathy at Hospital de Clinicas de
Porto Alegre (HCPA) and at the Ophthalmology Outpatient Clinic at HCPA,

Exclusion Criteria:

- patients with type 2 DM and previous treatment of diffuse macular oedema secondary to
diabetic retinopathy